Chang‐Hsien Lu

A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer

J.S. Chen, Chih‐Hung Hsu, Nai‐Jung Chiang et al. · Annals of Oncology · 2015 · 157 citations

Gastrointestinal Oncology, Medicine, Biliary Cancer +7

The prognosis of head and neck squamous cell carcinoma related to immunosuppressive tumor microenvironment regulated by IL-6 signaling

Ming‐Shao Tsai, Wen‐Cheng Chen, Chang‐Hsien Lu et al. · Oral Oncology · 2019 · 64 citations

Cancer Immunosurveillance, Immunology, Pathology +8

Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity

Wen‐Cheng Chen, Tzer-Zen Hwang, Wen–Hung Wang et al. · Oral Oncology · 2008 · 61 citations

Adaptive Radiotherapy, Surgical Oncology, Radiation Therapy +10

Expression and function role of DNA methyltransferase 1 in human bladder cancer

Chun‐Te Wu, Ching‐Fang Wu, Chang‐Hsien Lu et al. · Cancer · 2011 · 44 citations · Full text

Chromogranin A Is a Reliable Biomarker for Gastroenteropancreatic Neuroendocrine Tumors in an Asian Population of Patients

Wen‐Chi Chou, Yu‐Shin Hung, Jun‐Te Hsu et al. · Neuroendocrinology · 2012 · 42 citations